Re: Exempt Distribution

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Telepanel

Rank: Treasurer [?]

Points: 1140 [?]

Votes: 22 Score: 2.2 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Exempt Distribution

in response to

Re: Exempt Distribution

Nextblockbuster

posted on Feb 19, 2021 02:17PM

If you look on company website you can see the valuation for accounting purposes which is way higher than OTC.You could probably pick up 75k overtime on Oct but an order for 50k on the OTC would have the mm on the hop

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply